West Bengal Nipah cluster prompts regional screenings and monitoring

Two confirmed cases of Nipah virus disease among hospital staff in West Bengal have prompted stepped‑up surveillance across the region, though Indian authorities say the outbreak is contained and contacts have tested negative. European and international health agencies are monitoring the cluster closely as neighboring countries tighten airport checks and border screening.

European Centre for Disease Prevention and Control officials cited Indian authorities’ report that the two cases are health‑care workers who had contact while on duty in late December 2025. Indian health officials notified the World Health Organization in late January and told investigators they had identified, traced and tested 196 contacts; those traced contacts remain asymptomatic and all tested negative, the ECDC said. India’s Ministry of Health and Family Welfare said the situation “is under constant monitoring, and all necessary public health measures are in place,” and that enhanced surveillance, laboratory testing and field investigations are ongoing.

The confirmed patients have been described in media reports as young nurses, both aged 25, though Indian authorities have not released patient names or detailed clinical status in their public statements. Early reports in some outlets cited higher case counts and lower quarantine totals; the ministry said those figures were “speculative and incorrect,” and that its more recent case and contact totals reflect laboratory confirmation and active tracing.

Public health teams have been deployed to the hospital setting where the exposures occurred to enforce infection control and to review how the two staff members were exposed. A U.S. Department of Health and Human Services spokesperson said an Indian outbreak response team had been deployed and the U.S. Centers for Disease Control and Prevention is “monitoring” the situation and in contact with local officials. One infectious‑disease expert quoted in recent coverage warned that health‑care exposures often stem from lapses in basic precautions: “proper standard precautions were not followed, such as not wearing gloves or masks.” The same expert said the chance of wider global spread is low: “The world is small, but the likelihood that somebody's infected, or an infected fruit bat with Nipah virus would be here, right now, is very unlikely.”

Several countries across Asia instituted or reinforced screening measures for travelers arriving from India. Thailand stepped up airport screenings and health declarations for selected flights, Nepal introduced checks at Kathmandu and land border posts, and Indonesia, Myanmar and Vietnam intensified temperature screening and passenger monitoring. China reported increasing border‑area disease prevention measures and training for medical staff. The ECDC assessed the risk to Europeans as “very low” based on the limited number of cases and their apparent link to a single health‑care setting.

Clinically, Nipah is a zoonotic virus carried by fruit bats that can spread to people through direct or indirect contact and sometimes between humans via close contact or bodily fluids. There is no approved vaccine; treatment is supportive. The WHO has estimated past case fatality rates for Nipah infections in outbreaks at roughly 40 to 75 percent, depending on the event and detection.

As investigations continue, Indian authorities say they have contained the cluster through contact tracing, quarantine and testing. WHO and CDC officials remain engaged with local teams to monitor for any signs of wider transmission and to advise on infection control measures.